US4634714AExpiredUtility

Inhibition of prolactin release by a benzodioxinylimidazoline derivative

28
Assignee: AMERICAN HOME PRODPriority: Dec 1, 1983Filed: Dec 1, 1983Granted: Jan 6, 1987
Est. expiryDec 1, 2003(expired)· nominal 20-yr term from priority
Inventors:Eric L. Lien
A61K 31/415
28
PatentIndex Score
0
Cited by
10
References
2
Claims

Abstract

2-(2,3-Dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1_H-imidazole, or a pharmaceutically acceptable salt thereof, is useful in the treatment of hyperprolactinemic states in warm-blooded animals.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method for lowering blood serum prolactin levels in warm-blooded animals which comprises administering, orally or parenterally, to a warm-blooded animal in need of a lowered serum prolactin level an amount of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof, sufficient to lower said serum prolactin level. 
     
     
       2. A method for lowering blood serum prolactin levels in a mammal which comprises administering, orally or parenterally, to a mammal in need of a lowered serum prolactin level, an amount of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole, or a pharmaceutically acceptable acid addition salt thereof, sufficient to lower said serum prolactin level.

Join the waitlist — get patent alerts

Track US4634714A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.